Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)
This study has been completed.
Sponsor:
MAP Pharmaceuticals, Inc.
Collaborator:
Q-Pharm Pty Limited
Information provided by:
MAP Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00627679
First received: February 22, 2008
Last updated: January 23, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2006 |
| Primary Completion Date: | December 2005 (Final data collection date for primary outcome measure) |